FLGT Q1 2022 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q1 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$320M-10.9% YoY

Gross Profit

$243M75.7% margin

Operating Income

$202M63.1% margin

Net Income

$154M48.1% margin

EPS (Diluted)

$4.93

QoQ Revenue Growth

+27.3%

Cash Flow

Operating Cash Flow

$188M

Free Cash Flow

$183M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$153M

Stockholders' Equity

$1.3B

Cash & Equivalents

$353M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$320M	$359M	-10.9%
Gross Profit	$243M	$285M	-15.0%
Operating Income	$202M	$267M	-24.3%
Net Income	$154M	$201M	-23.3%

Geographic Segments

U S

$317M99%

Non Us

$3M1%